UK: A recent consensus statement from leading UK medical organizations—including the Association of Anaesthetists, the ...

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Knowing what to do if you’re prone to dips in your blood sugar can help keep you safe. You may try fast-acting juice or glucose, or adjust your insulin dose to help quickly raise your blood ...

R. China, Zhengzhou, Henan Province, China; qqyyiillyy{at}126.com Objectives The protective role of sodium glucose cotransporter 2 (SGLT2) inhibitors in renal outcomes has been revealed by large ...

Background: Diabetic ketoacidosis (DKA) is an endocrine emergency with associated risk of morbidity and mortality. Despite this, DKA management lacks strong evidence due to the absence of large ...

Our data suggest SGLT2 inhibition as a safe strategy to prevent kidney stone recurrence in patients with kidney stones. “The general denominator of empagliflozin therapy was the dramatic increase in ...

Chicken is as American as apple pie. It’s tasty, versatile, economical, and easy to prepare. But chicken can often be battered and fried, coated in a sweet glaze, or swimming in a sugary sauce.

ABSTRACT: Introduction: Diabetic ketoacidosis (DKA) is the most common metabolic complication of diabetes. Although historically reported in children, it is increasingly observed in adults. Short-term ...

Over time, high blood sugar levels can progress to diabetes or cause complications of diabetes. Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar nonketotic syndrome (HHNS) or hyperglycemic ...

while dapagliflozin was associated with a lower risk of diabetic ketoacidosis. To TCTMD, Wiviott said there is a large body of evidence supporting the SGLT2 inhibitor drug class, noting the ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Comparative ...